Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2019-05-31
Target enrollment:
Participant gender:
Summary
This trial is to evaluate the potential of colchicine for the palliative management of
hepatocellular carcinoma patients with distant metastasis or large vessel invasion using the
Department of Health R.O.C. approved doses and methods of administration.
Phase:
Phase 2
Details
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital